big breakout this week in usa

We will see new highs this week in USA !!! Still no interest in Australia .

Psivida has a real big Potential ...

Market Cap 54,055,520 US$
Price 2.96 $

Shares Outstanding 18,262,000
52W High : 3,05 $

Upcoming Event:
PSIVIDA CORP at Rodman & Renshaw Annual Global Investment Conference
Wednesday, September 9, 2009


Major Shareholder:
http://phx.corporate-ir.net/phoenix.zhtml?c=168274&p=irol-ownershipSummary


Technology

How many license agreements does pSivida have?
We have four license agreements. Bausch and Lomb has licensed both the Vitrasert device and the Retisert device, Alimera the Iluvien device and Pfizer the Medidur technology

How many FDA approved products have you developed?
We have 2 FDA approved products, Vitrasert and Retisert. Both are being sold by Bausch and Lomb

How many products do you have in pivotal Phase III trials?
One, Iluvien for Diabetic Macular Edema (DME)

Are there any FDA approved drug treatments for DME?
There are presently no FDA approved drug treatments for DME

Who is funding the cost of the Iluvien pivotal Phase III Study?
Our licensing partner Alimera Sciences is funding the full cost of the trial that has almost 1,000 patients enrolled across the US, Europe and Asia